Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Buy” by Analysts

Privia Health Group, Inc. (NASDAQ:PRVA) has been assigned a consensus recommendation of “Buy” from the eighteen brokerages that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $24.88.

Several brokerages recently issued reports on PRVA. Needham & Company LLC assumed coverage on shares of Privia Health Group in a research report on Friday, January 10th. They set a “buy” rating and a $25.00 price target on the stock. KeyCorp assumed coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 price target on the stock. Macquarie started coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target for the company. Barclays upped their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Finally, Truist Financial raised their price target on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th.

Privia Health Group Stock Down 3.0 %

Shares of PRVA opened at $22.69 on Friday. The stock has a market cap of $2.72 billion, a price-to-earnings ratio of 226.92, a P/E/G ratio of 3.09 and a beta of 0.87. The company has a 50-day moving average price of $21.32 and a two-hundred day moving average price of $20.06. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $23.62.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Proficio Capital Partners LLC bought a new position in Privia Health Group in the 4th quarter valued at about $464,000. Atria Investments Inc raised its position in shares of Privia Health Group by 11.9% during the fourth quarter. Atria Investments Inc now owns 14,014 shares of the company’s stock worth $274,000 after acquiring an additional 1,494 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of Privia Health Group by 62.0% in the fourth quarter. Victory Capital Management Inc. now owns 290,009 shares of the company’s stock worth $5,670,000 after acquiring an additional 110,960 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of Privia Health Group by 6.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,133,873 shares of the company’s stock worth $22,167,000 after buying an additional 69,649 shares during the period. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Privia Health Group by 108.1% in the 4th quarter. Smartleaf Asset Management LLC now owns 7,275 shares of the company’s stock valued at $142,000 after purchasing an additional 3,779 shares during the period. 94.48% of the stock is owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.